MetaCap

Biodexa Pharmaceuticals American Depositary Shs (BDRX) vs Capstone (CAPS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Capstone is the larger company by market cap ($1.3 million vs $982,950), about 1.4 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BDRX+232.56%CAPS+927.84%
+2018%+941%-136%
Oct 7, 20261 yearNov 20, 2026
BDRX+307.43%CAPS+949.56%
+1879%+876%-128%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BDRX versus CAPS key metrics
MetricBDRXCAPS
Share price$1.88$1.44
Market cap$982.95K$1.35M
1-day change-3.85%-9.15%
P/E ratio (TTM)0.00—
EPS (TTM)$509.89$-89.68
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$46.88M
Revenue growth (YoY)—+4.47%
Net income (latest FY)—$-21.23M
Gross margin—23.02%
Operating margin—-23.43%
Net margin—-45.28%
52-week high$357.60$28.50
52-week low$1.85$1.42
Distance from 52-week high-99.48%-94.95%
Analyst consensusnonenone
Avg. price target upside+375.20%+108.33%
Average volume618.91K153.70K
Shares outstanding524.24K935.38K
Employees1193
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Biodexa Pharmaceuticals American Depositary Shs

BDRX stock →

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer. Its lead product candidate, Tolimidone, is a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.

Health Care · Biotechnology: Pharmaceutical Preparations · 11 employees

About Capstone

CAPS stock →

Capstone Holding Corp., through its subsidiaries, engages in the distribution and installation of building products in the United States and Canada. It operates in two segments, TotalStone and Carolina Stone.

Health Care · Biotechnology: Pharmaceutical Preparations · 93 employees

BDRX vs CAPS FAQ

Which is bigger, Biodexa Pharmaceuticals American Depositary Shs or Capstone?

Capstone (CAPS) is larger, with a market capitalization of $1.35M compared with $982.95K for Biodexa Pharmaceuticals American Depositary Shs (BDRX).

Are Biodexa Pharmaceuticals American Depositary Shs and Capstone in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons